Skip to content
Drug recall · FDA · Published July 30, 2018

NuCare Pharmaceuticals Inc recalls Valsartan/HCTZ 320/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC

NuCare Pharmaceuticals recalls 320/25mg Valsartan/HCTZ tablets due to detected carcinogen impurity in manufacturing. This may pose cancer risk. Check your prescription label for NDC 68071-4183-3.

🇺🇸 FDA recall #D-1039-2018DrugNuCare Pharmaceuticals ›
Take action

Contact the company & request your remedy

Recalling firmNuCare Pharmaceuticals Inc622 W Katella Ave, N/A · Orange, CA 92867-4608
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

NuCare Pharmaceuticals is recalling 320/25mg Valsartan/HCTZ tablets because a carcinogen was found in the manufacturing process. This could increase cancer risk for people taking the medication. Read more at govinfonow.com/recall/39836-nucare-valsartan-hctz-tablets-recall-carcinogen-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39836-nucare-valsartan-hctz-tablets-recall-carcinogen-impurity-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-1039-2018

Cite this page

“NuCare Valsartan/HCTZ Tablets Recall: Carcinogen Impurity Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39836-nucare-valsartan-hctz-tablets-recall-carcinogen-impurity-risk. Based on FDA recall #D-1039-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1039-2018%22&limit=1).

Why it’s dangerous

The recall is for a carcinogen impurity detected in the active pharmaceutical ingredient used to make the drug. This impurity could potentially increase cancer risk over time when taken regularly.

Who’s affected

People with a prescription for these specific tablets are affected. Those taking the medication for blood pressure or other conditions may be at risk.

How to tell if you have this one

Check your prescription label for the product name 'Valsartan/HCTZ 320/25mg Tablets', 30-count jar, Rx Only. Look for NDC 68071-4183-3 and lot number T11577.

  • Brand
    NuCare Pharmaceuticals
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distributed to three customers in Fl and CA
Recall numberProduct, codes & lots
D-1037-2018Valsartan/HCTZ 160/12.5 mg Tablets, 90-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4311-9; Lot # U01779; Exp. 04/30/2019
D-1038-2018Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,; Lot # T11443; Exp. 02/28/2019
D-1039-2018Valsartan/HCTZ 320/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4183-3; Lot # T11577; Exp. 06/30/2019
Based on the official FDA remedy

What to do — step by step

  1. Check Your Prescription Label

    Look for the product name 'Valsartan/HCTZ 320/25mg Tablets', 30-count jar, Rx Only, NDC 68071-4183-3, and lot number T11577.

✎ GovInfoNow

Questions people ask

Is this product safe to take?

The recall states a carcinogen impurity was detected in the manufacturing process, but the official notice does not specify if the product is safe to take.

How can I check if I have the recalled product?

Check your prescription label for the product name 'Valsartan/HCTZ 320/25mg Tablets', 30-count jar, Rx Only, NDC 68071-4183-3, and lot number T11577.

What should I do if I have the recalled product?

The recall notice does not specify a remedy, so the official notice does not say what to do next.

Take action

Contact NuCare Pharmaceuticals

We’ve drafted a message you can send NuCare Pharmaceuticals to request your refund or repair — edit it as you like.

Subject: Recall D-1039-2018 — NuCare Pharmaceuticals NuCare Pharmaceuticals

Hello,

I own a NuCare Pharmaceuticals that is covered by recall D-1039-2018 from NuCare Pharmaceuticals.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1039-2018 (July 30, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1039-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA